Ledger.Open graph →
SEC Form D · filed September 21, 2017

SPR Therapeutics, Inc

Offering
$18.8M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
CLEVELAND, OH
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Jeffrey E. Sokol · Birmingham, ALDirectorGreg E. Maletsky · Highland Park, ILDirectorAlan E. Mitrani · TEANECK, NJExecKenneth J. Krebs · COLUMBUS, OHExecDavid A. Kornbluth · Orange Village, OHExecJames T. Merkel · COLUMBUS, OHDirectorDavid C. Fox · College Station, TXDirectorGordon A. Schaeffer · Santa Fe, NMExec · DirectorJeffrey M. Drazan · SAN MATEO, CADirectorGretchen L. Bergstresser · New York, NYDirectorKenneth C. Largess · Boston, MAExec · DirectorHamish H. Burt · New York, NYExecJonathan Friesel · New York, NYExecScott Radell · San Francisco, CADirectorNicholas Kalaitzandonakes · Maryland Heights, MOExecJean A. Sabatier · EDEN PRAIRIE, MNDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗